Abstract
The prevalence of insomnia and depression is higher in women than it is in men, although women show better sleep when measured using polysomnography measurements. The risk of insomnia and depression in women specifically increases during life phases when sex hormones strongly fluctuate, such as pregnancy and menopause. This study examined the effects of sex hormone use (also called gender-affirming hormone therapy, or GAHT) by transgender persons on reported depressive symptoms and sleep quality.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
